PACLITAXELUM ACCORD

Concentrate for solution for infusion, 6mg/ml
RxActive license

Active substance (INN)

paclitaxel

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength6mg/ml
PackagingUkupno 1 bočica staklena sa 50ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAccord Healthcare Polska Sp. z o.o., Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01CD01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateMarch 25, 2026

Analogs in Montenegro

8

Other medicines with the same active substance

ABRAXANERx
Powder for dispersion for infusion, 5mg/mlCelgene Distribution B.V.
PACLITAXEL EBEWERx
Concentrate for solution for infusion, 100mg/16.7mlFareva Unterach GmbH
PACLITAXEL EBEWERx
Concentrate for solution for infusion, 30mg/5mlFareva Unterach GmbH
PACLITAXELUM ACCORDRestricted
Concentrate for solution for infusion, 6mg/mlAccord Healthcare Polska Sp. z o.o.
PATAXELRx
Concentrate for solution for infusion, 100mg/16.7mlVianex S.A. - Plant C
PATAXELRestricted
Concentrate for solution for infusion, 30mg/5mlVianex S.A. - Plant C
SINDAXEL®Rx
Concentrate for solution for infusion, 30mg/5mlS. C. Sindan-Pharma S.r.l.
SINDAXEL®Rx
Concentrate for solution for infusion, 100mg/16.67mlS. C. Sindan-Pharma S.r.l.
Source: CInMED register